 | • レポートコード：MRC2102QY5903 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のグルカゴン様ペプチド-1（GLP-1）アゴニスト市場について種類別（エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、デュラグルチド）、用途別（病院、薬局、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・グルカゴン様ペプチド-1（GLP-1）アゴニスト市場の概要 ・世界の主要地域別グルカゴン様ペプチド-1（GLP-1）アゴニスト市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のグルカゴン様ペプチド-1（GLP-1）アゴニスト市場規模2015-2026：種類別（エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、デュラグルチド） ・世界のグルカゴン様ペプチド-1（GLP-1）アゴニスト市場規模2015-2026：用途別（病院、薬局、その他） ・グルカゴン様ペプチド-1（GLP-1）アゴニストの米国市場規模2015-2020 ・グルカゴン様ペプチド-1（GLP-1）アゴニストのヨーロッパ市場規模2015-2020 ・グルカゴン様ペプチド-1（GLP-1）アゴニストの中国市場規模2015-2020 ・グルカゴン様ペプチド-1（GLP-1）アゴニストの日本市場規模2015-2020 ・グルカゴン様ペプチド-1（GLP-1）アゴニストの東南アジア市場規模2015-2020 ・グルカゴン様ペプチド-1（GLP-1）アゴニストのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・グルカゴン様ペプチド-1（GLP-1）アゴニストの製造コスト分析 ・販売チャネル、流通業者、顧客 ・グルカゴン様ペプチド-1（GLP-1）アゴニストの市場動向・機会・課題 ・調査の結論 |
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
United States is the largest consumer of Glucagon like peptide-1 (GLP-1) agonists with the production market share of 35% and the consumption market share of 44% in 2015.
Market Analysis and Insights: Global Glucagon Like Peptide-1 (GLP-1) Agonists Market
The global Glucagon Like Peptide-1 (GLP-1) Agonists market size is projected to reach US$ 16460 million by 2026, from US$ 7781.9 million in 2020, at a CAGR of 13.3% during 2021-2026.
Global Glucagon Like Peptide-1 (GLP-1) Agonists Scope and Market Size
The global Glucagon Like Peptide-1 (GLP-1) Agonists market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glucagon Like Peptide-1 (GLP-1) Agonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Glucagon Like Peptide-1 (GLP-1) Agonists market is segmented into
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Segment by Application, the Glucagon Like Peptide-1 (GLP-1) Agonists market is segmented into
Hospital
Pharmacy
Other
The Glucagon Like Peptide-1 (GLP-1) Agonists market is analysed and market size information is provided by regions (countries). Segment by Application, the Glucagon Like Peptide-1 (GLP-1) Agonists market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
Glucagon Like Peptide-1 (GLP-1) Agonists market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glucagon Like Peptide-1 (GLP-1) Agonists business, the date to enter into the Glucagon Like Peptide-1 (GLP-1) Agonists market, Glucagon Like Peptide-1 (GLP-1) Agonists product introduction, recent developments, etc.
The major vendors covered:
Novo Nordisk
AstraZeneca
Eli Lilly
GSK
Sanofi
Bristol-Myers Squibb
Amylin
1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Product Scope
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type
1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2020-2026)
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
1.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts (2015-2026)
1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2015-2026)
1.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2015-2026)
1.4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Trends (2015-2026)
2 Glucagon Like Peptide-1 (GLP-1) Agonists Estimate and Forecast by Region
2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2015-2020)
2.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2015-2020)
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2015-2026)
2.4.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2015-2026)
2.4.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2015-2026)
2.4.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2015-2026)
2.4.6 India Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2015-2026)
3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Competition Landscape by Players
3.1 Global Top Glucagon Like Peptide-1 (GLP-1) Agonists Players by Sales (2015-2020)
3.2 Global Top Glucagon Like Peptide-1 (GLP-1) Agonists Players by Revenue (2015-2020)
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2019)
3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Company (2015-2020)
3.5 Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Glucagon Like Peptide-1 (GLP-1) Agonists Players (Opinion Leaders)
4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Review by Type (2015-2020)
4.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
4.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2015-2020)
4.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2015-2020)
4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Type (2021-2026)
4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Type (2021-2026)
4.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Type (2021-2026)
5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Review by Application (2015-2020)
5.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
5.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2015-2020)
5.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2015-2020)
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Application (2021-2026)
5.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Application (2021-2026)
5.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Application (2021-2026)
6 United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
6.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
6.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
6.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
7 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
7.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
7.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
7.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
8 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
8.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
8.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
8.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
9 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
9.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (3015-3030)
9.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
9.3 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
10 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
10.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
11 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
11.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
11.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
11.3 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Glucagon Like Peptide-1 (GLP-1) Agonists Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Corporation Information
12.1.2 Novo Nordisk Business Overview
12.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Business Overview
12.3.3 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.3.5 Eli Lilly Recent Development
12.4 GSK
12.4.1 GSK Corporation Information
12.4.2 GSK Business Overview
12.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.4.5 GSK Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Business Overview
12.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.5.5 Sanofi Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Business Overview
12.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Amylin
12.7.1 Amylin Corporation Information
12.7.2 Amylin Business Overview
12.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.7.5 Amylin Recent Development
…
13 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Cost Analysis
13.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
13.4 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
14.3 Glucagon Like Peptide-1 (GLP-1) Agonists Customers
15 Market Dynamics
15.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends
15.2 Glucagon Like Peptide-1 (GLP-1) Agonists Opportunities and Drivers
15.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
15.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Region (2015-2020)
Table 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2015-2020)
Table 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Region (2015-2020)
Table 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share Forecast by Region (2021-2026)
Table 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists (K Units) of Key Companies (2015-2020)
Table 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Company (2015-2020)
Table 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Company (2015-2020)
Table 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2019)
Table 17. Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Sites and Area Served
Table 19. Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Glucagon Like Peptide-1 (GLP-1) Agonists Players
Table 22. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2015-2020)
Table 23. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2015-2020)
Table 24. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (K Units) by Type (2015-2020)
Table 26. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2021-2026)
Table 27. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2021-2026)
Table 29. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (K Units) by Type (2021-2026)
Table 30. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2015-2020)
Table 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2015-2020)
Table 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (K Units) by Application (2015-2020)
Table 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2021-2026)
Table 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2021-2026)
Table 36. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Application (2021-2026)
Table 38. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (K Units) by Application (2021-2026)
Table 39. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2015-2020)
Table 40. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
Table 41. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2015-2020)
Table 42. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
Table 43. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2015-2020)
Table 44. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
Table 45. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2015-2020)
Table 46. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
Table 47. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2015-2020)
Table 48. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
Table 49. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2015-2020)
Table 50. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
Table 51. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2015-2020)
Table 52. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
Table 53. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2015-2020)
Table 54. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
Table 55. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2015-2020)
Table 56. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
Table 57. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2015-2020)
Table 58. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
Table 59. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2015-2020)
Table 60. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
Table 61. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2015-2020)
Table 62. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
Table 69. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2015-2020)
Table 70. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2015-2020)
Table 71. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2015-2020)
Table 72. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
Table 73. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2015-2020)
Table 74. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
Table 75. Novo Nordisk Corporation Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 79. Novo Nordisk Recent Development
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 84. AstraZeneca Recent Development
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 89. Eli Lilly Recent Development
Table 90. GSK Corporation Information
Table 91. GSK Description and Business Overview
Table 92. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 94. GSK Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 99. Sanofi Recent Development
Table 100. Bristol-Myers Squibb Corporation Information
Table 101. Bristol-Myers Squibb Description and Business Overview
Table 102. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 104. Bristol-Myers Squibb Recent Development
Table 105. Amylin Corporation Information
Table 106. Amylin Description and Business Overview
Table 107. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 109. Amylin Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
Table 113. Glucagon Like Peptide-1 (GLP-1) Agonists Customers List
Table 114. Glucagon Like Peptide-1 (GLP-1) Agonists Market Key Trends
Table 115. Glucagon Like Peptide-1 (GLP-1) Agonists Key Opportunities and Drivers
Table 116. Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Product Picture
Figure 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Other Examples
Figure 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Glucagon Like Peptide-1 (GLP-1) Agonists Players Market Share by Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists 2015 & 2019
Figure 27. Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2015-2020)
Figure 29. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Application (2015-2020)
Figure 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2019
Figure 33. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2019
Figure 34. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company in 2019
Figure 35. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2019
Figure 36. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2019
Figure 37. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company in 2019
Figure 38. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2019
Figure 39. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2019
Figure 40. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company in 2019
Figure 41. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2019
Figure 42. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2019
Figure 43. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company in 2019
Figure 44. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2019
Figure 45. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2019
Figure 46. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company in 2019
Figure 47. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2019
Figure 48. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure 51. Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure 52. Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
ナトリウム利尿ペプチドの世界市場レポート2020 Market Analysis and Insights: Global Natriuretic Peptide Market The global Natriuretic Peptide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Natriuretic Peptide Scope and Market Size The global Natriuretic Peptide mar…- ペプチドシンセサイザーの世界市場レポート2020 Peptide Synthesizer is an instrument used for peptide synthesis according to the principle of solid phase peptide synthesis. Peptides are used to prepare epitope-specific antibodies, map antibody epitopes and enzyme binding sites and to design novel enzymes, drugs and vaccines. Peptide synthesis is …
- ペプチド合成の世界市場レポート2020 Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress to…
- ペプチド抗生物質の世界市場レポート2020 Market Analysis and Insights: Global Peptide Antibiotics Market The global Peptide Antibiotics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Peptide Antibiotics Scope and Market Size The global Peptide Antibiotics mar…
- 抗菌ペプチドの世界市場レポート2020 Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, bro…